Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dexamfetamine 125mg/5ml oral liquid
0404000L0AAAPAP
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 15mg modified-release capsules
0404000L0AAABAB
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 2.5mg/5ml oral liquid
0404000L0AAATAT
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 20mg/5ml oral solution
0404000L0AABJBJ
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 3mg/5ml oral liquid
0404000L0AAAUAU
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 45mg/5ml oral liquid
0404000L0AABBBB
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 5mg modified-release capsules
0404000L0AABCBC
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexamfetamine 7.5mg/5ml oral liquid
0404000L0AAARAR
|
Dexamfetamine sulfate | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 10mg Spansules
0404000L0BBAEBA
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 15mg Spansules
0404000L0BBADAB
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 5mg Spansules
0404000L0BBAFBC
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
|
Dexedrine 5mg tablets
0404000L0BBAAAJ
|
Dexedrine | Dexamfetamine sulfate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.